SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

KLRA.O (KLRA.O) News

Track canonical SquawkNews coverage tagged to KLRA.O, KLRA.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol KLRA.O Asset market Sector Markets 90 days 1 Updated Sep 30, 2026, 11:06 AM UTC Open live news feed
M Kailera Therapeutics completes enrollment in KaiNETIC Phase 3 ribupatide obesity trials Kailera Therapeutics completed enrollment in its global Phase 3 KaiNETIC program testing once-weekly ribupatide injection, with topline data expected mid-2028. EARNINGS | Sep 30, 2026, 11:06 AM UTC